Effect of chemical composition and state of the surface on the toxic response to high aspect ratio nanomaterials

Nanomedicine

Volumn 6, Issue 5, 2011, Pages 899-920

  Fubini, Bice ^a   Fenoglio, Ivana ^a   Tomatis, Maura ^a   Turci, Francesco ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

asbestos; carbon nanotubes; carbon wires; free radical generation; free radical quenching; free radicals; gold nanorods; high aspect ratio nanomaterials; hydrophilicity hydrophobicity; nanochrysotile; nanotoxicology; nanowires

Indexed keywords

AMPHIBOLE; ASBESTOS; CARBON NANOFIBER; CARBON NANOTUBE; CHRYSOTILE; METAL OXIDE; NANOMATERIAL; NANOPARTICLE; NANOROD; NANOWIRE; OXIDE;

BIOCOMPATIBILITY; CHEMICAL COMPOSITION; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING;

ANIMALS; ASBESTOS; HUMANS; METALS; NANOFIBERS; NANOSTRUCTURES; NANOTUBES; NANOTUBES, CARBON; OXIDES;

EID: 79960932881     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.80     Document Type: Review

References (184)

1. Oberdorster G, Stone V, Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1(1), 2-25 (2007). (Pubitemid 46570244)
2. Oberdorster G, Maynard A, Donaldson K et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2, 8 (2005).
3. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113(7), 823-839 (2005). (Pubitemid 40984181)
4. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 311(5761), 622-627 (2006). (Pubitemid 43191298)
5. Maynard A, Rejeski D. Too small to overlook. Nature 460(7252), 174-174 (2009).
6. Hong SY, Tobias G, Al-Jamal KT et al. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nature Mater. 9(6), 485-490 (2010).
7. Fubini B. Surface reactivity in the pathogenic response to particulates. Environ. Health Perspect. 105, 1013-1020 (1997).
8. Fubini B, Fenoglio I. Toxic potential of mineral dusts. Elements 3(6), 407-414 (2007).
9. Donaldson K, Murphy F, Schinwald A, Duffin R, Poland CA. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (Lond.) 6(1), 143-156 (2011).
10. Tomatis M, Turci F, Ceschino R et al. High aspect ratio materials: role of surface chemistry vs. length in the historical "long and short amosite asbestos fibers. Inhalation Toxicol. 22(12), 984-998 (2010).
11. Ghiazza M, Polimeni M, Fenoglio I, Gazzano E, Ghigo D, Fubini B. Does vitreous silica contradict the toxicity of the crystalline silica paradigm? Chem. Res. Toxicol. 23(3), 620-629 (2010).
12. Warheit DB, Webb TR, Colvin VL, Reed KL, Sayes CR. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol. Sci. 95(1), 270-280 (2007). (Pubitemid 44942796)
13. Warheit DB, Reed KL, Sayes CM. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhalation Toxicol. 21(Suppl. 1), 61-67 (2009).
14. Maxim LD, Mcconnell EE. A review of the toxicology and epidemiology of wollastonite. Inhalation Toxicol. 17(9), 451-466 (2005). (Pubitemid 40875321)
15. WHO. Workshop on mechanisms of fibre carcinogenesis and assessment of chrysotile asbestos substitutes. Consensus report. (2005).
16. Bonelli B, Bottero I, Ballarini N, Passeri S, Cavani F, Garrone E. IR spectroscopic and catalytic characterization of the acidity of imogolite-based systems. J. Catalysis 264(1), 15-30 (2009).
17. Fubini B, Ghiazza M, Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 4(4), 347-363 (2010).
18. Bussolati O, Rotoli BM, Zanello PP et al. Nanotubes of the Aluminosilicate Imogolite exhibit mild Toxicity for Macrophages and Airway Epithelial Cells. Part. Fibre Toxicol. (2011) (Submitted)
19. Iijima S. Helical microtubules of graphitic carbon. Nature 354(6348), 56-58 (1991). (Pubitemid 21896780)
20. Galano A, Francisco-Marquez M, Martinez A. Influence of point defects on the free-radical scavenging capability of single-walled carbon nanotubes. J. Phys. Chem. C 114(18), 8302-8308 (2010).
21. Endo M, Strano MS, Ajayan PM. Potential applications of carbon nanotubes. Carbon Nanotubes 111, 13-61 (2008).
22. Hirsch A, Vostrowsky O. Functionalization of carbon nanotubes. In: Functional Molecular Nanostructures. Springer-Verlag Berlin, Berlin, Germany, 193-237 (2005). (Pubitemid 44423491)
23. Banerjee S, Hemraj-Benny T, Wong SS. Covalent surface chemistry of single-walled carbon nanotubes. Adv. Mater. 17(1), 17-29 (2005). (Pubitemid 40178440)
24. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug Deliv. Rev. 58(14), 1460-1470 (2006). (Pubitemid 44822607)
25. Liu CH, Zhang HL. Chemical approaches towards single-species single-walled carbon nanotubes. Nanoscale 2(10), 1901-1918 (2010).
26. Zhang YN, Zheng LX. Towards chirality-pure carbon nanotubes. Nanoscale 2(10), 1919-1929 (2010).
27. Kostarelos K. The emergence of nanomedicine: a field in the making. Nanomedicine 1(1), 1-3 (2006).
28. Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine (Lond.) 5(1), 89-97 (2010).
29. Cheung W, Pontoriero F, Taratula O, Chen AM, He H. DNA and carbon nanotubes as medicine. Adv. Drug Deliv. Rev. 62(6), 633-649 (2010).
30. Sato Y, Shibata K, Kataoka H et al. Strict preparation and evaluation of water-soluble hatstacked carbon nanofibers for biomedical application and their high biocompatibility: influence of nanofiber-surface functional groups on cytotoxicity. Mol. Biosyst. 1(2), 142-145 (2005). (Pubitemid 43362240)
31. Zanello LP, Zhao B, Hu H, Haddon RC. Bone cell proliferation on carbon nanotubes. Nano Lett. 6(3), 562-567 (2006).
32. Koyama S, Haniu H, Osaka K et al. Medical application of carbon-nanotube-fitted nanocomposites: the microcatheter. Small 2(12), 1406-1411 (2006). (Pubitemid 44786880)
33. Hu H, Ni YC, Montana V, Haddon RC, Parpura V. Chemically functionalized carbon nanotubes as substrates for neuronal growth. Nano Lett. 4(3), 507-511 (2004). (Pubitemid 38402642)
34. Roach P, Parker T, Gadegaard N, Alexander MR. Surface strategies for control of neuronal cell adhesion: a review. Surface Sci. Report 65(6), 145-173 (2010).
35. Donaldson K, Aitken R, Tran L et al. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol.Sci. 92(1), 5-22 (2006). (Pubitemid 43985785)
36. Kane AB, Hurt RH. Nanotoxicology: the asbestos analogy revisited. Nat. Nanotechnol. 3(7), 378-379 (2008). (Pubitemid 351948250)
37. Kostarelos K. The long and short of carbon nanotube toxicity. Nat. Biotechnol. 26(7), 774-776 (2008). (Pubitemid 351961446)
38. Shvedova AA, Kisin ER, Porter D et al. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus? Pharmacol. Therapeut. 121(2), 192-204 (2009).
39. Pacurari M, Castranova V, Vallyathan V. Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans? J. Toxicol. Environ. Health A 73(5), 378-395 (2010).
40. Lison D, Muller J. Untitled. Toxicol. Sci. 101(1), 179-180 (2008).
41. Muller J, Huaux F, Moreau N et al. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 207(3), 221-231 (2005). (Pubitemid 41207915)
42. Kagan VE, Tyurina YY, Tyurin VA et al. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron. Toxicol. Lett. 165(1), 88-100 (2006). (Pubitemid 43867182)
43. Ma-Hock L, Treumann S, Strauss V et al. Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. Toxicol. Sci. 112(2), 468-481 (2009).
44. Elgrabli D, Floriani M, Abella-Gallart S et al. Biodistribution and clearance of instilled carbon nanotubes in rat lung. Part. Fibre Toxicol. 5, (2008).
45. Takagi A, Hirose A, Nishimura T et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J. Toxicol. Sci. 33(1), 105-116 (2008). (Pubitemid 351340768)
46. Sakamoto Y, Nakae D, Fukumori N et al. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male fischer 344 rats. J. Toxicol. Sci. 34, 65-76 (2009).
47. Poland CA, Duffin R, Kinloch I et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3(7), 423-428 (2008).
48. Kolosnjaj-Tabi J, Hartman KB, Boudjemaa S et al. In vivo behavior of large doses of ultrashort and full-length single-walled carbon nanotubes after oral and intraperitoneal administration to swiss mice. ACS Nano 4(3), 1481-1492 (2010).
49. Vittorio O, Raffa V, Cuschieri A. Influence of purity and surface oxidation on cytotoxicity of multiwalled carbon nanotubes with human neuroblastoma cells. Nanomedicine 5(4), 424-431 (2009).
50. Muller J, Huaux F, Fonseca A et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: toxicological aspects. Chem. Res. Toxicol. 21, 1698-1705 (2008).
51. Fenoglio I, Greco G, Tomatis M et al. Structural defects play a major role in the acute lung toxicity of multiwall carbon nanotubes: physicochemical aspects. Chem. Res. Toxicol. 21, 1690-1697 (2008).
52. Wang X, Jia G, Wang H et al. Diameter effects on cytotoxicity of multi-walled carbon nanotubes. J. Nanosci. Nanotechnol. 9(5), 3025-3033 (2009).
53. Yamashita K, Yoshioka Y, Higashisaka K et al. Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape. Inflammation 33(4), 276-280 (2010).
54. Johnston HJ, Hutchison GR, Christensen FM et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: the contribution of physico-chemical characteristics. Nanotoxicology 4(2), 207-246 (2010).
55. Muller J, Delos M, Panin N, Rabolli V, Huaux F, Lison D. Absence of carcinogenic response to multiwall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicol. Sci. 110(2), 442-448 (2009).
56. Falini G, Foresti E, Gazzano M et al. Tubular-shaped stoichiometric chrysotile nanocrystals. Chem. Eur. J. 10(12), 3043-3049 (2004).
57. Foresti E, Fornero E, Lesci IG, Rinaudo C, Zuccheri T, Roveri N. Asbestos health hazard: A spectroscopic study of synthetic geoinspired Fe-doped chrysotile. J. Hazard. Mater. 167(1-3), 1070-1079 (2009).
58. Gazzano E, Foresti E, Lesci IG et al. Different cellular responses evoked by natural and stoichiometric synthetic chrysotile asbestos. Toxicol. Appl. Pharmacol. 206(3), 356-364 (2005). (Pubitemid 41020678)
59. Gazzano E, Turci F, Foresti E et al. Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. Chem. Res. Toxicol. 20(3), 380-387 (2007). (Pubitemid 46548684)
60. Foresti E, Hochella MF, Kornishi H et al. Morphological and chemical/physical characterization of Fe-doped synthetic chrysotile nanotubes. Adv. Funct. Mater. 15(6), 1009-1016 (2005). (Pubitemid 40844287)
61. Turci F, Tomatis M, Lesci IG, Roveri N, Fubini B. The iron-related molecular toxicity mechanism of synthetic asbestos nanofibres: a model study for high-aspect-ratio nanoparticles. Chem. Eur. J. 17(1), 350-358 (2011).
62. Service RF. Nanotubes: the next asbestos? Science 281(5379), 941-942 (1998).
63. Jaurand M-CF, Renier A, Daubriac J. Mesothelioma: do asbestos and carbon nanotubes pose the same health risk? Part. Fibre Toxicol. 6, 16 (2009).
64. Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB. Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol. 1(5), 511-529 (2009).
65. Nagai H, Toyokuni S. Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials. Arch. Biochem. Biophys. 502(1), 1-7 (2010).
66. Veblen DR, Wylie AG. Mineralogy of amphiboles and 1/1 layer silicates. Rev. Mineral. 28, 61-137 (1993).
67. Warheit DB. What is currently known about the health risks related to carbon nanotube exposures? Carbon 44(6), 1064-1069 (2006). (Pubitemid 43202163)
68. Timbrell V, Gibson JC, Webster I. UICC standard reference samples of asbestos. Int. J. Cancer 3(3), 406-408 (1968).
69. 2 polymorphs from the enthalpy of adsorption of various molecules. Langmuir 9(10), 2712-2720 (1993).
70. Girifalco LA, Hodak M, Lee RS. Carbon nanotubes, buckyballs, ropes, and a universal graphitic potential. Phys. Rev. B 62(19), 13104-13110 (2000). (Pubitemid 32322426)
71. Peigney A, Laurent C, Flahaut E, Bacsa RR, Rousset A. Specific surface area of carbon nanotubes and bundles of carbon nanotubes. Carbon 39(4), 507-514 (2001). (Pubitemid 32263502)
72. Wick P, Manser P, Limbach LK et al. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol. Lett. 168(2), 121-131 (2007). (Pubitemid 46054362)
73. Liu XY, Hurt RH, Kane AB. Biodurability of single-walled carbon nanotubes depends on surface functionalization. Carbon 48(7), 1961-1969 (2010).
74. Choi HS, Frangioni JV. Nanoparticles for biomedical imaging: fundamentals of clinical translation. Mol. Imaging 9(6), 291-310 (2010).
75. Fenoglio I, Fubini B, Ghibaudi E, Turci F. Multiple aspects of the interaction of biomacromolecules with inorganic surfaces. Adv. Drug Deliv. Rev. (2011) (Accepted for publication).
76. Aust AE, Lund LG, Chao CC, Park SH, Fang RH. Role of iron in the cellular effects of asbestos. Inhalation Toxicol. 12, 75-80 (2000).
77. Aust AE. Role of iron in the biological effects of asbestos. Abstr. Am. Chem. Soc. 224, U732-U732 (2002).
78. Guo L, Morris DG, Liu X, Vaslet C, Hurt RH, Kane AB. Iron bioavailability and redox activity in diverse carbon nanotube samples. Chem. Mater. 19(14), 3472-3478 (2007). (Pubitemid 47155026)
79. Kim H, Sigmund W. Iron particles in carbon nanotubes. Carbon 43(8), 1743-1748 (2005). (Pubitemid 40744131)
80. Zalma R, Guignard J, Copin E, Pezerat H. Studies on surface properties of asbestos. IV. Catalytic role of asbestos in fluorene oxidation. Environ. Res. 41(1), 296-301 (1986). (Pubitemid 16000855)
81. Pezerat H, Zalma R, Guignard J, Jaurand MC. Production of oxygen radicals by the reduction of oxygen arising from the surface activity of mineral fibres. IARC Scientific Pub. 90, 100-111 (1989).
82. Kamp DW, Weitzman SA. The molecular basis of asbestos induced lung injury. Thorax 54(7), 638-652 (1999). (Pubitemid 29296687)
83. Hardy JA, Aust AE. Iron in asbestos chemistry and carcinogenicity. Chem. Rev. 95(1), 97-118 (1995).
84. Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT. Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radical Biol. Med. 34(9), 1117-1129 (2003). (Pubitemid 36423362)
85. Fubini B, Mollo L. Role of iron in the reactivity of mineral fibers. Toxicol. Lett. 82-83, 951-960 (1995). (Pubitemid 26054775)
86. Martra G, Tomatis M, Fenoglio I, Coluccia S, Fubini B. Ascorbic acid modifies the surface of asbestos: possible implications in the molecular mechanisms of toxicity. Chem. Res. Toxicol. 16(3), 328-335 (2003). (Pubitemid 36373697)
87. Turci F, Favero-Longo SE, Tomatis M et al. A biomimetic approach to the chemical inactivation of chrysotile fibres by lichen metabolites. Chem. Eur. J. 13(14), 4081-4093 (2007). (Pubitemid 46925616)
88. Hardy JA, Aust AE. The effect of iron-binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. Carcinogenesis 16(2), 319-325 (1995).
89. Liu SW, Tang XH, Mastai Y, Felner I, Gedanken A. Preparation and characterization of iron-encapsulating carbon nanotubes and nanoparticles. J. Mater. Chem. 10(11), 2502-2506 (2000).
90. Pulskamp K, Diabate S, Krug HF. Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants. Toxicol. Lett. 168(1), 58-74 (2007). (Pubitemid 44909723)
91. Jacobsen NR, Pojana G, White P et al. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C60 fullerenes in the FE1-Mutatrade markMouse lung epithelial cells. Environ. Mol. Mutagen. 49(6), 476-487 (2008).
92. Folkmann JK, Risom L, Jacobsen NR, Wallin H, Loft S, Moller P. Oxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubes. Environ. Health Perspect. 117(5), 703-708 (2009).
93. Porter DW, Hubbs AF, Mercer RR et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269(2-3), 136-147 (2010).
94. Crouzier D, Follot S, Gentilhomme E et al. Carbon nanotubes induce inflammation but decrease the production of reactive oxygen species in lung. Toxicology 272(1-3), 39-45 (2010).
95. Vallyathan V, Mega JF, Shi XL, Dalal NS. Enhanced generation of free-radicals from phagocytes induced by mineral dusts. Am. J. Respir. Cell Mol. Biol. 6(4), 404-413 (1992).
96. Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Investigation 14(5), 466-480 (1996). (Pubitemid 26338211)
97. Manning CB, Vallyathan V, Mossman BT. Diseases caused by asbestos: mechanisms of injury and disease development. Int. Immunopharmacol. 2(2-3), 191-200 (2002). (Pubitemid 34075410)
98. Manna SK, Sarkar S, Barr J et al. Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-k B in human keratinocytes. Nano Lett. 5(9), 1676-1684 (2005). (Pubitemid 41396145)
99. Monteiro-Riviere NA, Inman AO, Wang YY, Nemanich RJ. Surfactant effects on carbon nanotube interactions with human keratinocytes. Nanomedicine 1(4), 293-299 (2005). (Pubitemid 43963644)
100. Pacurari M, Yin XJ, Zhao J et al. Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-k B, and Akt in normal and malignant human mesothelial cells. Environ. Health Perspect. 116(9), 1211-1217 (2008).
101. Sharma CS, Sarkar S, Periyakaruppan A et al. Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells. J. Nanosci. Nanotechnol. 7(7), 2466-2472 (2007).
102. Shvedova AA, Castranova V, Kisin ER et al. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A 66(20), 1909-1926 (2003). (Pubitemid 37352634)
103. Brown DM, Kinloch IA, Bangert U et al. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 45(9), 1743-1756 (2007). (Pubitemid 47069251)
104. Watts PCP, Fearon PK, Hsu WK, Billingham NC, Kroto HW, Walton DRM. Carbon nanotubes as polymer antioxidants. J. Mater. Chem. 13(3), 491-495 (2003).
105. Fenoglio I, Tomatis M, Lison D et al. Reactivity of carbon nanotubes: free radical generation or scavenging activity? Free Radical Biol. Med. 40(7), 1227-1233 (2006).
106. Lucente-Schultz RM, Moore VC, Leonard AD et al. Antioxidant single-walled carbon nanotubes. J. Am. Chem. Soc. 131(11), 3934-3941 (2009).
107. Gilmore JL, Yi X, Quan L, Kabanov AV. Novel nanomaterials for clinical neuroscience. J. Neuroimmune Pharmacol. 3(2), 83-94 (2008).
108. Galano A. Influence of diameter, length, and chirality of single-walled carbon nanotubes on their free radical scavenging capability. J. Phys. Chem. C 113(43), 18487-18491 (2009).
109. Martinez A, Galano A. Free radical scavenging activity of ultrashort single-walled carbon nanotubes with different structures through electron transfer reactions. J. Phys. Chem. C 114(18), 8184-8191 (2010).
110. Shukla PK, Mishra PC. Effects of diameter, length, chirality and defects on the scavenging action of single-walled carbon nanotubes for OH radicals: a quantum computational study. Chem. Phys. 369(2-3), 101-107 (2010).
111. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408(6809), 239-247 (2000).
112. Churg A, Wright JL. Persistence of natural mineral fibers in human lungs: an overview. Environ. Health Perspect. 102(Suppl. 5), 229-233 (1994). (Pubitemid 24364859)
113. Churg A, Wright JL, Gilks B, Depaoli L. Rapid short-term clearance of chrysotile compared with amosite asbestos in the guinea-pig. Am. Rev. Respir. Dis. 139(4), 885-890 (1989). (Pubitemid 19094309)
114. Churg A. Deposition and clearance of chrysotile asbestos. Ann. Occup. Hyg. 38(4), 625-625 (1994).
115. Coin PG, Roggli VL, Brody AR. Deposition, clearance, and translocation of chrysotile asbestos from peripheral and central regions of the rat lung. Environ. Res. 58(1), 97-116 (1992).
116. Berry G. Models for mesothelioma incidence following exposure to fibers in terms of timing and duration of exposure and the biopersistence of the fibers. Inhalation Toxicol. 11(2), 111-130 (1999). (Pubitemid 29068717)
117. Deng X, Jia G, Wang H et al. Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon 45(7), 1419-1424 (2007). (Pubitemid 46829028)
118. Lam CW, James JT, Mccluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci. 77(1), 126-134 (2004). (Pubitemid 38128652)
119. Kagan VE, Konduru NV, Feng WH et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 5(5), 354-359 (2010).
120. Liu X, Guo L, Morris D, Kane AB, Hurt RH. Targeted removal of bioavailable metal as a detoxification strategy for carbon nanotubes. Carbon 46(3), 489-500 (2008).
121. Forrest GA, Alexander AJ. A model for the dependence of carbon nanotube length on acid oxidation time. J. Phys. Chem. C 111(29), 10792-10798 (2007). (Pubitemid 47218094)
122. Oberdorster G, Morrow PE, Spurny K. Size dependent lymphatic short term clearance of amosite fibers in the lung. Ann. Occup. Hyg. 32, 149-156 (1988).
123. Dodson RF, Williams MG Jr, Corn CJ, Brollo A, Bianchi C. Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am. Rev. Respir. Dis. 142(4), 843-847 (1990). (Pubitemid 20344655)
124. Dodson RF, Atkinson MA, Levin JL. Asbestos fiber length as related to potential pathogenicity: a critical review. Am. J. Ind. Med. 44(3), 291-297 (2003). (Pubitemid 37082210)
125. Shvedova AA, Kisin E, Murray AR et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 295(4), L552-L565 (2008).
126. Li JG, Li WX, Xu JY et al. Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation. Environ. Toxicol. 22(4), 415-421 (2007).
127. Warheit DB. Long-term inhalation toxicity studies with multiwalled carbon nanotubes: closing the gaps or initiating the debate? Toxicol. Sci. 112(2), 273-275 (2009).
128. Ryman-Rasmussen JP, Cesta MF, Brody AR et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat. Nanotechnol. 4(11), 747-751 (2009).
129. Mercer RR, Scabilloni J, Wang L et al. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 294(1), L87-L97 (2008). (Pubitemid 351380321)
130. Kane AB, Macdonald JL, Moalli PA. Acute injury and regeneration of mesothelial cells produced by crocidolite asbestos fibers. Am. Rev. Respir. Dis. 133(4), A198-A198 (1986).
131. Moalli PA, Macdonald JL, Goodglick LA, Kane AB. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Pathol. 128(3), 426-445 (1987). (Pubitemid 17139894)
132. Donaldson K, Murphy F, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part. Fibre Toxicol. 7, 5-22 (2010).
133. Endo M, Kim YA, Hayashi T et al. Structural characterization of cup-stacked-type nanofibers with an entirely hollow core. Appl. Phys. Lett. 80(7), 1267-1269 (2002).
134. Rodriguez NM, Chambers A, Baker RTK. Catalytic engineering of carbon nanostructures. Langmuir 11(10), 3862-3866 (1995).
135. De Jong KP, Geus JW. Carbon nanofibers: catalytic synthesis and applications. Catalysis Rev. Sci. Eng. 42(4), 481-510 (2000).
136. Tran PA, Zhang LJ, Webster TJ. Carbon nanofibers and carbon nanotubes in regenerative medicine. Adv. Drug Deliv. Rev. 61(12), 1097-1114 (2009).
137. Helland A, Wick P, Koehler A, Schmid K, Som C. Reviewing the environmental and human health knowledge base of carbon nanotubes. Environ. Health Perspect. 115(8), 1125-1131 (2007). (Pubitemid 351816702)
138. Methner M, Hodson L, Dames A, Geraci C. Nanoparticle emission assessment technique (NEAT) for the identification and measurement of potential inhalation exposure to engineered nanomaterials-part B: results from 12 field studies. J. Occup. Environ. Hyg. 7(3), 163-176 (2010).
139. Eedy DJ. Carbon-fibre-induced airborne irritant contact dermatitis. Contact Dermatitis 35(6), 362-363 (1996). (Pubitemid 27067569)
140. Jenkinson HA. Contact dermatitis in a chimney sweep. Contact Dermatitis 37(1), 35 (1997). (Pubitemid 27322994)
141. Monteiro-Riviere NA, Inman AO. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 44(6), 1070-1078 (2006). (Pubitemid 43202164)
142. Gogotsi Y. How safe are nanotubes and other nanofilaments? Mater. Res. Innovations 7(4), 192-194 (2003).
143. Yokoyama A, Sato Y, Nodasaka Y et al. Biological behavior of hat-stacked carbon nanofibers in the subcutaneous tissue in rats. Nano Lett. 5(1), 157-161 (2005). (Pubitemid 40168920)
144. Grabinski C, Hussain S, Lafdi K, Braydich-Stolle L, Schlager J. Effect of particle dimension on biocompatibility of carbon nanomaterials. Carbon 45(14), 2828-2835 (2007). (Pubitemid 350086566)
145. Lindberg HK, Falck GCM, Suhonen S et al. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol. Lett. 186(3), 166-173 (2009).
146. Magrez A, Kasas S, Salicio V et al. Cellular toxicity of carbon-based nanomaterials. Nano Lett. 6(6), 1121-1125 (2006). (Pubitemid 44013471)
147. Vamvakaki V, Tsagaraki K, Chaniotakis N. Carbon nanofiber-based glucose biosensor. Anal. Chem. 78(15), 5538-5542 (2006). (Pubitemid 44182375)
148. Kisin ER, Murray AR, Sargent L et al. Genotoxicity of carbon nanofibers: are they potentially more or less dangerous than carbon nanotubes or asbestos? Toxicol. Appl. Pharmacol. 252(1), 1-10 (2011).
149. Huang WH, Ferris JP. One-step, regioselective synthesis of up to 50-mers of RNA oligomers by montmorillonite catalysis. J. Am. Chem. Soc. 128(27), 8914-8919 (2006). (Pubitemid 44061549)
150. Lee KS, El-Sayed MA. Dependence of the enhanced optical scattering efficiency relative to that of absorption for gold metal nanorods on aspect ratio, size, end-cap shape, and medium refractive index. J. Phys. Chem. B 109(43), 20331-20338 (2005). (Pubitemid 41609758)
151. Jana NR, Gearheart L, Murphy CJ. Wet chemical synthesis of high aspect ratio cylindrical gold nanorods. J. Phys. Chem. B 105(19), 4065-4067 (2001). (Pubitemid 35381537)
152. Sau TK, Murphy CJ. Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir 20(15), 6414-6420 (2004).
153. Murphy CJ, San TK, Gole AM et al. Anisotropic metal nanoparticles. Synthesis, assembly, and optical applications. J. Phys. Chem. B 109(29), 13857-13870 (2005). (Pubitemid 41163090)
154. Qiu Y, Liu Y, Wang L et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31(30), 7606-7619 (2010).
155. Parab HJ, Chen HM, Lai TC et al. Biosensing, cytotoxicity, and cellular uptake studies of surface-modified gold nanorods. J. Phys. Chem. C 113(18), 7574-7578 (2009).
156. Leonov AP, Zheng J, Clogston JD, Stern ST, Patri AK, Wei A. Detoxification of gold nanorods by treatment with polystyrenesulfonate. ACS Nano 2(12), 2481-2488 (2008).
157. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 5(6), 701-708 (2009).
158. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1(3), 325-327 (2005). (Pubitemid 43951781)
159. Murphy CJ, Thompson LB, Alkilany AM et al. The many faces of gold nanorods. J. Phys. Chem. Lett. 1(19), 2867-2875 (2010).
160. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662-668 (2006).
161. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 422(6927), 37-44 (2003). (Pubitemid 36323287)
162. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell "sees in bionanoscience. J. Am. Chem. Soc. 132(16), 5761-5768 (2010).
163. Turci F, Ghibaudi E, Colonna M, Boscolo B, Fenoglio I, Fubini B. an integrated approach to the study of the interaction between proteins and nanoparticles. Langmuir 26(11), 8336-8346 (2010).
164. Hauck TS, Ghazani AA, Chan WCW. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4(1), 153-159 (2008). (Pubitemid 351205749)
165. Weizmann Y, Lim J, Chenoweth DM, Swager TM. Regiospecific synthesis of Au-nanorod/SWCNT/Au-nanorod heterojunctions. Nano Lett. 10(7), 2466-2469 (2010).
166. Patolsky F, Zheng G, Lieber CM. Nanowire-based biosensors. Anal. Chem. 78(13), 4260-4269 (2006).
167. Wang J. Biomolecule-functionalized nanowires: from nanosensors to nanocarriers. Chemphyschem. 10(11), 1748-1755 (2009).
168. Lorenz MR, Holzapfel V, Musyanovych A et al. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27(14), 2820-2828 (2006). (Pubitemid 43165751)
169. Muller KH, Kulkarni J, Motskin M et al. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS Nano 4(11), 6767-6779 (2010).
170. Prina-Mello A, Diao Z, Coey J. Internalization of ferromagnetic nanowires by different living cells. J. Nanobiotechnol. 4(1), 9 (2006).
171. Choi D, Fung A, Moon H et al. Transport of living cells with magnetically assembled nanowires. Biomed. Microdevices 9(2), 143-148 (2007). (Pubitemid 46554121)
172. Song MM, Song WJ, Bi H et al. Cytotoxicity and cellular uptake of iron nanowires. Biomaterials 31(7), 1509-1517 (2010).
173. Kostarelos K, Lacerda L, Pastorin G et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat. Nanotechnol. 2(2), 108-113 (2007). (Pubitemid 46230832)
174. Kwon NH, Beaux MF, Ebert C et al. Nanowire-based delivery of Escherichia coli O157 shiga toxin 1 A subunit into human and bovine cells. Nano Lett. 7(9), 2718-2723 (2007). (Pubitemid 47522427)
175. Qi SJ, Yi CQ, Chen WW, Fong CC, Lee ST, Yang MS. Effects of silicon nanowires on HepG2 cell adhesion and spreading. Chembiochem. 8(10), 1115-1118 (2007).
176. Adili A, Crowe S, Beaux MF et al. Differential cytotoxicity exhibited by silica nanowires and nanoparticles. Nanotoxicology 2(1), 1-8 (2008).
177. Julien DC, Richardson CC, Beaux MF, Mcilroy DN, Hill RA. In vitro proliferating cell models to study cytotoxicity of silica nanowires. Nanomedicine 6(1), 84-92 (2010).
178. Napierska D, Thomassen LCJ, Lison D, Martens JA, Hoet PH. The nanosilica
179. Beaux MF, Bridges NJ, Dehart M, Bitterwolf TE, Mcilroy DN. X-ray photoelectron spectroscopic analysis of the surface chemistry of silica nanowires. Appl. Surf. Sci. 257(13), 5766-5771 (2011).
180. Byrne F, Prina-Mello A, Whelan A et al. High content analysis of the biocompatibility of nickel nanowires. J. Magn. Magn. Mater. 321(10), 1341-1345 (2009).
181. Kasprzak KS, Sunderman FW Jr, Salnikow K. Nickel carcinogenesis. Mutat. Res. 533(1-2), 67-97 (2003). (Pubitemid 37487861)
182. Li Z, Yang RS, Yu M, Bai F, Li C, Wang ZL. Cellular level biocompatibility and biosafety of ZnO nanowires. J. Phys. Chem. C 112(51), 20114-20117 (2008).
183. Kuo C-W, Shiu J-Y, Kung Hwa W, Peilen C. Functionalized silver nanowires for live cell study. Chem. Lett. 37(6), 610-611 (2008).
184. Kuo C-W, Lai J-J, Kung Hwa W, Peilen C. Surface modified gold nanowires for mammalian cell transfection. Nanotechnology 19(2), 025103 (2008).